Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / Ordinary Share $0.00001 Par Value
Shares outstanding
51,428,000
Total 13F shares
20,412,218
Share change
-837,733
Total reported value
$304,588,647
Put/Call ratio
0.75%
Price per share
$14.92
Number of holders
86
Value change
-$33,281,851
Number of buys
44
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
12%
6,061,228
$139,711,000 30 Sep 2014
13F
VANGUARD GROUP INC
13F
Company
2.9%
1,467,246
$33,820,000 30 Sep 2014
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
2.8%
1,449,791
$33,418,000 30 Sep 2014
13F
FIRST MANHATTAN CO. LLC.
13F
Company
2.4%
1,222,665
$28,182,000 30 Sep 2014
13F
STATE STREET CORP
13F
Company
2.2%
1,112,037
$25,637,000 30 Sep 2014
13F
OppenheimerFunds, Inc.
13F
Company
2.1%
1,085,745
$25,027,000 30 Sep 2014
13F
Foundation Asset Management, LP
13F
Company
1.7%
855,616
$19,722,000 30 Sep 2014
13F
BlackRock Fund Advisors
13F
Company
1.5%
767,562
$17,692,000 30 Sep 2014
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
1.4%
709,756
$16,360,000 30 Sep 2014
13F
D. E. Shaw & Co., Inc.
13F
Company
1.3%
689,334
$15,889,000 30 Sep 2014
13F
First Eagle Investment Management, LLC
13F
Company
0.89%
455,330
$10,495,000 30 Sep 2014
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.88%
454,474
$10,475,000 30 Sep 2014
13F
PERRY CAPITAL
13F
Company
0.84%
433,488
$9,992,000 30 Sep 2014
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.67%
345,045
$7,953,000 30 Sep 2014
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.63%
324,337
$7,593,000 30 Sep 2014
13F
FMR LLC
13F
Company
0.58%
298,948
$6,891,000 30 Sep 2014
13F
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD
13F
Company
0.58%
296,234
$6,828,000 30 Sep 2014
13F
NORTHERN TRUST CORP
13F
Company
0.52%
265,536
$6,121,000 30 Sep 2014
13F
NORGES BANK
13F
Company
0.48%
245,617
$5,662,000 30 Sep 2014
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.45%
230,712
$5,318,000 30 Sep 2014
13F
GUGGENHEIM CAPITAL LLC
13F
Company
0.39%
200,724
$4,627,000 30 Sep 2014
13F
Rock Springs Capital Management LP
13F
Company
0.3%
155,500
$3,584,000 30 Sep 2014
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.27%
137,793
$3,176,000 30 Sep 2014
13F
HighVista Strategies LLC
13F
Company
0.26%
134,214
$3,094,000 30 Sep 2014
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.26%
131,760
$3,037,000 30 Sep 2014
13F
State of New Jersey Common Pension Fund D
13F
Company
0.24%
125,459
$2,892,000 30 Sep 2014
13F
Bank of New York Mellon Corp
13F
Company
0.23%
120,497
$2,777,000 30 Sep 2014
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.21%
107,743
$2,483,000 30 Sep 2014
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
100,141
$2,307,000 30 Sep 2014
13F
ROYCE & ASSOCIATES LP
13F
Company
0.18%
95,000
$2,190,000 30 Sep 2014
13F
MORGAN STANLEY
13F
Company
0.18%
94,858
$2,187,000 30 Sep 2014
13F
CREDIT SUISSE AG/
13F
Company
0.18%
93,152
$2,145,000 30 Sep 2014
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.17%
86,200
$1,987,000 30 Sep 2014
13F
Laurion Capital Management LP
13F
Company
0.14%
74,370
$1,714,000 30 Sep 2014
13F
BlackRock Investment Management, LLC
13F
Company
0.13%
69,013
$1,591,000 30 Sep 2014
13F
Absolute Return Capital, LLC
13F
Company
0.13%
68,634
$1,582,000 30 Sep 2014
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.12%
61,746
$1,424,000 30 Sep 2014
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.11%
56,611
$1,305,000 30 Sep 2014
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.08%
43,480
$1,002,000 30 Sep 2014
13F
Roundview Capital LLC
13F
Company
0.08%
39,969
$921,000 30 Sep 2014
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.07%
37,127
$856,000 30 Sep 2014
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.07%
34,969
$806,000 30 Sep 2014
13F
TEACHERS ADVISORS, LLC
13F
Company
0.06%
32,920
$759,000 30 Sep 2014
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
29,120
$671,000 30 Sep 2014
13F
Swiss National Bank
13F
Company
0.05%
26,142
$603,000 30 Sep 2014
13F
Realm Partners LLC
13F
Company
0.05%
24,757
$571,000 30 Sep 2014
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
0.05%
23,869
$550,000 30 Sep 2014
13F
C WorldWide Group Holding A/S
13F
Company
0.04%
21,857
$518,000 30 Sep 2014
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
19,474
$449,000 30 Sep 2014
13F
MANAGED ACCOUNT ADVISORS LLC
13F
Company
0.04%
18,334
$422,000 30 Sep 2014
13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q4 2014

As of 31 Dec 2014, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,412,218 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, FIRST MANHATTAN CO, BlackRock Fund Advisors, OPPENHEIMER FUNDS INC, State Street Corp, Foundation Asset Management, LP, BlackRock Institutional Trust Company, N.A., D. E. Shaw & Co., Inc., and ROYCE & ASSOCIATES LLC. This page lists 86 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2014 vs Q3 2014 Across Filers

Q3 2014 holders
86
Q4 2014 holders
86
Holder diff
0
Investor Q3 2014 Shares Q4 2014 Shares Share Diff Share Chg % Q3 2014 Value $ Q4 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.